ABSTRACT
On April 3, 2020, Rishi Bhargav, Chief Executive Officer of Ashian Biotech, held a videoconference with his senior management team regarding the company's future. Lately, he had been under fire from the company's board since Ashian was not pursuing new opportunities aggressively, unlike other biotech firms.
